Medical Research Future Fund Grants - submission via NHMRC Granting System (now Sapphire)

Status

OPEN/FORECAST OPPORTUNITIES

Internal deadlines

Respiratory Medicine Clinical Trials Research on COVID-19 Grant Opportunity

STAGEREQ'DSUBMISSION
Applications open in Sapphire

23 Mar 2020

Submit Notice of Intent to
Submit (NOIS) form

M

27 Mar 2020

Email Deakin Research Grants

Minimum data requirements 

Not applicable

Final application in Sapphire,
Certification and Consent forms

M

***9am 6 Apr 2020***

Email snapshot reports and all uploaded documents to Deakin NHMRC Submissions

Email DU Certification form(s) and AI consent(s) to Deakin NHMRC Submissions

Antiviral Development for COVID-19 Grant Opportunity

STAGEREQ'DSUBMISSION
Applications open in Sapphire

25 Mar 2020

Submit Notice of Intent to
Submit (NOIS) form

M

31 Mar 2020

Email Deakin Research Grants

Minimum data requirements 

Not applicable

Final application in Sapphire,
Certification and Consent forms

M

***9am 8 Apr 2020***

Email snapshot reports and all uploaded documents to Deakin NHMRC Submissions

Email DU Certification form(s) and AI consent(s) to Deakin NHMRC Submissions

O - Optional / M - Mandatory

Overview

The Medical Research Future Fund (MRFF) provides grants of financial assistance to support health and medical research and innovation, with the objective of improving the health and wellbeing of Australians.

NHMRC is working with the Department of Health to implement a number of disbursement from the MRFF. This assistance will draw on NHMRC’s high quality application and assessment processes and the expertise available to NHMRC through the health and medical research sector.

Respiratory Medicine Clinical Trials Research on COVID-19 Grant Opportunity

Applications must propose a clinical trial that accelerates the implementation of treatments for severe acute respiratory distress in patients infected with COVID-19 in order to support the response to the COVID-19 outbreak in Australia. Applicants should note that the research funded by this grant opportunity is not intended to be used for development of vaccines or anti-viral therapies for COVID-19. These issues are the subject of separate MRFF grant opportunities.

The objective of the 2020 Respiratory Medicine Clinical Trials Research on COVID-19 Grant Opportunity is to use clinical trials to accelerate the implementation of treatments for severe acute respiratory distress in patients infected with COVID 19. To be competitive for funding, applicants must propose a clinical trial that delivers against the above objective.

The intended outcome of the research funded under this priority is to use clinical trials to accelerate the implementation of safe and effective treatments for severe acute respiratory distress in patients infected with COVID 19. This includes the identification of plausible pathways to clinical practice within 12 months of commencement.

Applications must address the desired outcomes described in section 1.3 of the grant guidelines.

Antiviral Development for COVID-19 Grant Opportunity

Applications must propose research to rapidly identify antiviral candidates targeting SARS-CoV-2 (new and repurposed) and accelerate promising effective treatments that can be made available to treat Australians infected with SARS-CoV-2.

A competitive two stage funding process will be used:

Stage 1: Funding of up to $3 million will be provided to support testing of up to 10 antiviral candidates for stability, safety and effectiveness against SARS-CoV-2 to demonstrate proof of concept. Stage 1 projects are to be completed within 9 months of commencement.

Stage 2: Funding of up to $5 million will support acceleration of promising antiviral candidates from Stage 1 into clinical practice, enabling clinical trials in humans, progression through regulatory pathways and/or transition to commercialisation. Stage 2 projects are to be completed within 24 months of commencement.

Applicants should note that the research funded by this grant opportunity is not intended to be used for vaccine development or respiratory medicine research for COVID-19. These issues are the subject of separate MRFF grant opportunities.

How to apply

  1. Liaise with your faculty/institute/SRC.
  2. Submit a Notice of Intention to Submit (NOIS) form by email to research-grants@deakin.edu.au
  3. Read the Grant Guidelines and Peer Review Documents available via GrantConnect
  4. Commence your application in the NHMRC Research Grants Management System - Sapphire.
  5. Contact DR-Grants NHMRC team if you have any queries.
  6. Organise relevant Certification form. AI consent statements are no longer required.
  7. Final application must be on Sapphire by Final Application due date: email snapshot reports, certification form & all uploaded documents to Deakin NHMRC Submissions

Resources

MRFF documents

Please check specific MRFF scheme webpages for Guidelines, Proposal Templates and Peer Review information.

Applicants will need to register and log into GrantConnect to download the applicable documentation.

Respiratory Medicine Clinical Trials Research on COVID-19 Grant Opportunity; Click on GO Documents in GrantConnect

Antiviral Development for COVID-19 Grant Opportunity; Click on GO Documents in GrantConnect

Deakin University documents